FRIDAY DEADLINE NOTICE: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Emergent BioSolutions Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the FirmNewsfile Corp • 06/16/21
Last Few Days to Actively Participate in Emergent BioSolutions Inc. (EBS) Class Action: Bronstein, Gewirtz & Grossman, LLCNewsfile Corp • 06/16/21
FRIDAY DEADLINE REMINDER: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Emergent BioSolutions Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the FirmNewsfile Corp • 06/15/21
Deadline Approaching for Emergent BioSolutions Investors: Berger Montague Reminds Investors of Approaching Deadline in Securities Fraud Class Action Against Emergent BioSolutions Inc. (EBS); Lead Plaintiff Deadline is June 18, 2021Newsfile Corp • 06/14/21
COVID-19 Vaccine Drug Substance Manufactured by Emergent BioSolutions Authorized as Part of Johnson & Johnson's Emergency Use AuthorizationGlobeNewsWire • 06/11/21
EMERGENT BIOSOLUTIONS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuits Against Emergent BioSolutions Inc. - EBSNewsfile Corp • 06/11/21
Deadline in 8 Days: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Class Action Lawsuit Against Emergent BioSolutions Inc. (EBS)Newsfile Corp • 06/10/21
Class Action Lawsuit Deadline: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Securities Fraud Class Action Lawsuit Filed Against Emergent BioSolutions Inc.PRNewsWire • 06/08/21
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Emergent BioSolutions Inc. Investors with Losses to Secure Counsel Before Important June 18 Deadline in Securities Class Action - EBSPRNewsWire • 06/05/21
EBS Shareholder Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Shareholders of Emergent BioSolutions Inc. of Deadline in Securities Fraud Class Action LawsuitNewsfile Corp • 06/04/21
Entwistle & Cappucci LLP Announces It Has Filed a Securities Class Action Against Emergent BioSolutions Inc. (NYSE: EBS)Business Wire • 06/03/21
HAGENS BERMAN Encourages Emergent BioSolutions (EBS) Investors to Contact the Firm Now, June 18th Deadline Approaching in Securities Fraud LawsuitNewsfile Corp • 06/03/21
Investor Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Deadline in Securities Fraud Class Action Lawsuit Filed Against Emergent BioSolutions Inc.PRNewsWire • 06/02/21
CLASS ACTION ALERT: Kessler Topaz Meltzer & Check, LLP Reminds Emergent BioSolutions Inc. Shareholders of Securities Fraud Class Action LawsuitNewsfile Corp • 05/31/21
EBS Breaking Notice: Rosen, Trusted National Trial Counsel, Encourages Emergent BioSolutions Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - EBSNewsfile Corp • 05/29/21
Kessler Topaz Meltzer & Check, LLP: Reminds Investors of Securities Fraud Class Action Filed Against Emergent BioSolutions Inc.PRNewsWire • 05/28/21
Emergent BioSolutions Poised To Receive FDA Nod to Restart J&J COVID-19 Shot Production at Baltimore Plant After Mishap: WSJBenzinga • 05/28/21
EBS INVESTOR REMINDER: Kessler Topaz Meltzer & Check, LLP Announces Deadline in Securities Fraud Class Action Lawsuit Filed Against Emergent BioSolutions Inc.Newsfile Corp • 05/27/21
Emergent BioSolutions's Single-Dose Chikungunya Vaccine Candidate Effective Even After Two Years of VaccinationBenzinga • 05/26/21
Emergent BioSolutions Announces Positive Two-Year Persistence Data From Phase 2 Study Evaluating CHIKV VLP, the Company's Chikungunya Virus Virus-Like Particle Vaccine CandidateGlobeNewsWire • 05/26/21
SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Emergent Biosolutions Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of June 18, 2021 - EBSNewsfile Corp • 05/25/21
HAGENS BERMAN Encourages Emergent BioSolutions (EBS) Investors to Contact the Firm Now, Securities Fraud Class Action FiledNewsfile Corp • 05/24/21